Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.65 |
| ▸ | FAAH | O00519 | 3/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28205315 | 1.00 | DGKA (0.65) | DGKAFAAHEPHX2KDM4EDUSP3 | |
| SCHEMBL6729478 | 0.92 | KDM4E (0.59) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL10441766 | 0.92 | KDM4E (0.59) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL6725646 | 0.92 | KDM4E (0.59) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL16558026 | 0.92 | KDM4E (0.59) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL9530596 | 0.92 | KDM4E (0.59) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL10441646 | 0.92 | KDM4E (0.59) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL1357229 | 0.92 | KDM4E (0.59) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL16449818 | 0.90 | EPHX2 (0.59) | DGKAFAAHEPHX2 | |
| SCHEMBL9683934 | 0.85 | ACHE (0.59) | KDM4EDUSP3MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9474916-B2 | Carbamates from glycerine carbonate for pearlization | EVONIK DEGUSSA GMBH (DE) | 2016-10-25 | — | — | US | disclosed |
| US-9474916-B2 | Carbamates from glycerine carbonate for pearlization | EVONIK DEGUSSA GMBH (DE) | 2016-10-25 | — | — | US | disclosed |
| US-20150044264-A1 | Carbamates from Glycerine Carbonate for Pearlization | EVONIK INDUSTRIES AG | 2015-02-12 | — | — | US | disclosed |
| US-20150044264-A1 | Carbamates from Glycerine Carbonate for Pearlization | EVONIK INDUSTRIES AG | 2015-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150044264-A1 | Carbamates from Glycerine Carbonate for Pearlization | SGMS2, SGMS1, PHOSPHO1 | DGKA 246/4885FAAH 1390/4885EPHX2 2494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.